ISO TS 17137-2021 PDF

ISO TS 17137-2021 PDF

Cardiovascular implants and extracorporeal systems-Cardiovascular absorbable implants

$129.00 $258.00 -50%
Product Code: ISO TS 17137
Stock In Stock
Edition: 3RD
Published: 09/2021
Number of Pages: 44
File Size: 1 file, 2 Bytes

Available Options

Product Description

Cardiovascular implants and extracorporeal systems — Cardiovascular absorbable implants

Introduction: Absorbable cardiovascular implants are medical devices with various clinical indications for use in the human cardiovascular blood system. An absorbable cardiovascular implant, or at least a portion thereof, is designed to intentionally degrade over time into degradation products that are absorbed by the body through either metabolism, assimilation, or excretion (elimination), or all. Such implants can be either surgically introduced or introduced through intervention to the site of treatment. This document outlines requirements for intended performance, design attributes, materials, design evaluation, manufacturing, sterilization, packaging, and information supplied by the manufacturer. This document is intended to be a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants. This document is intended to also be a supplement to relevant device-specific standards such as the ISO 25539 series specifying requirements for endovascular devices, which do not address degradation and other time dependent aspects of absorbable implants and coatings. Additionally, this document should be considered in conjunction with ISO 14155, which specifies proper practices in clinical investigations. This document is not comprehensive with respect to the pharmacological evaluation of cardiovascular absorbable implants. More detailed safety and performance requirements for pharmacological agents included in the absorbable cardiovascular imp

Scope: This document establishes design evaluation requirements and recommendations for absorbable cardiovascular implants used to treat vessels and/or the vascular space within the circulatory system, including the heart and all vasculature. This document is intended to supplement device-specific standards by providing guidelines specific for either absorbable implants or components, or both. This document is applicable to implants in direct contact with the cardiovascular system, where the intended action is upon the circulatory system. This document does not address the specific evaluation of issues associated with viable tissues, viable cells, and/or implants with non-viable biological materials and their derivatives. Additionally, procedures and devices used prior to and following the introduction of the absorbable cardiovascular implant (e.g. balloon angioplasty devices) are excluded from the scope of this document if they do not affect the absorption aspects of the implant. A cardiovascular absorbable implant can incorporate substance(s) which, if used separately, can be considered to be a medicinal product (drug product) but the action of the medicinal substance is ancillary to that of the implant and supports the primary mode of action of the implant. NOTE 1 Some aspects of absorbable components of cardiovascular device-drug combination products (e.g. coatings) in their connection with drug-related aspects of the device are addressed in ISO 12417-1. NOTE 2 An explanation of the nomenclature of absorb, degrade and related terms can be found in Annex A.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good
ISO TS 17137-2021 PDF

ISO TS 17137-2021 PDF

$129.00 $258.00